Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice

被引:314
作者
Jenkins, C
Costello, J
Hodge, L
机构
[1] Royal Prince Alfred Hosp, Woolcock Inst Med Res, Camperdown, NSW 2050, Australia
[2] Kings Coll Hosp London, London SE5 9RS, England
[3] Royal Prince Alfred Hosp, Asthma Ctr, Camperdown, NSW 2050, Australia
来源
BMJ-BRITISH MEDICAL JOURNAL | 2004年 / 328卷 / 7437期
关键词
D O I
10.1136/bmj.328.7437.434
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To reassess the prevalence of aspirin induced asthma and other issues related to the syndrome. Data sources Biosis, SciSearch (1990 to March 2002), Embase (1974 to March 2002), Medline (1966 to March 2002), Toxline, Derwent Drug File (1964 to March 2002), Conference Papers Index and Inside Conferences, Int'l Pharmaceutical Abstracts, Pharma-Online (1978 to March 2002). Selection criteria Study type, patient population, and outcome measures. Review was restricted to respiratory responses to analgesics avail able without prescription. Results The prevalence of aspirin induced asthma was highest when determined by oral provocation testing (adults 21%, 95% confidence interval 14% to 29%; children 5%, 0% to 14%) than by verbal history (adults 3%,2% to 4%; children 2%, 1% to 3%). Cross sensitivity to doses of over the counter non-steroidal anti-inflammatory drugs was present in most patients with aspirin induced asthma: ibuprofen, 98%; naproxen, 100%; and diclolenac, 93%. The incidence of cross sensitivity to paracetamol among such patients was only 7%. Conclusions Aspirin induced asthma in adults is more prevalent than previously suggested. When there is a clinical necessity to use aspirin or a non-steroidal anti-inflammatory drug and there is uncertainty about safety, oral provocation testing should be performed.
引用
收藏
页码:434 / 437
页数:6
相关论文
共 38 条
[1]  
BARLES PG, 1988, ALLERGOL IMMUNOPATH, V16, P321
[2]   PREVALENCE OF ASPIRIN INTOLERANCE IN ASTHMATICS TREATED IN A HOSPITAL [J].
CASTILLO, JA ;
PICADO, C .
RESPIRATION, 1986, 50 (03) :153-157
[3]   ASPIRIN INTOLERANCE .1. FREQUENCY IN AN ALLERGIC POPULATION [J].
CHAFEE, FH ;
SETTIPANE, GA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1974, 53 (04) :193-199
[4]   COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression [J].
Chandrasekharan, NV ;
Dai, H ;
Roos, KLT ;
Evanson, NK ;
Tomsik, J ;
Elton, TS ;
Simmons, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) :13926-13931
[5]   DIAGNOSIS OF ASPIRIN IDIOSYNCRASY BY ANALGESIC CHALLENGE [J].
DELANEY, JC .
CLINICAL ALLERGY, 1976, 6 (02) :177-181
[6]   ACETAMINOPHEN AND ASPIRIN CHALLENGES IN SUBGROUPS OF ASTHMATICS [J].
FALLIERS, CJ .
JOURNAL OF ASTHMA, 1983, 20 :39-49
[7]   ASPIRIN AND SUBTYPES OF ASTHMA - RISK FACTOR-ANALYSIS [J].
FALLIERS, CJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1973, 52 (03) :141-147
[8]  
FISCHER TJ, 1983, PEDIATRICS, V71, P313
[9]  
Ispano M, 1993, Drugs, V46 Suppl 1, P253
[10]   RATES OF SENSITIVITY REACTIONS TO ASPIRIN - PROBLEMS IN INTERPRETING THE DATA [J].
KWOH, CK ;
FEINSTEIN, AR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (05) :494-505